Selective targeting of bioengineered platelets to prostate cancer vasculature: new paradigm for therapeutic modalities
about
Megakaryocyte- and megakaryocyte precursor-related gene therapiesNanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Platelet-mimetic strategies for modulating the wound environment and inflammatory responses.Cell-Based Biohybrid Drug Delivery Systems: The Best of the Synthetic and Natural Worlds.Androgens modulate male-derived endothelial cell homeostasis using androgen receptor-dependent and receptor-independent mechanisms.
P2860
Selective targeting of bioengineered platelets to prostate cancer vasculature: new paradigm for therapeutic modalities
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Selective targeting of bioengi ...... igm for therapeutic modalities
@ast
Selective targeting of bioengi ...... igm for therapeutic modalities
@en
type
label
Selective targeting of bioengi ...... igm for therapeutic modalities
@ast
Selective targeting of bioengi ...... igm for therapeutic modalities
@en
prefLabel
Selective targeting of bioengi ...... igm for therapeutic modalities
@ast
Selective targeting of bioengi ...... igm for therapeutic modalities
@en
P2093
P2860
P356
P1476
Selective targeting of bioengi ...... igm for therapeutic modalities
@en
P2093
Alejandro S Godoy
Claudio H Morales
Gary J Smith
Ignacio F San Francisco
Sarah Burns
Thomas H Fischer
Viviana P Montecinos
P2860
P304
P356
10.1111/JCMM.12515
P577
2015-03-04T00:00:00Z